A Decision Framework Choose Semaglutide If: You are starting GLP-1 therapy for the first time and want to begin with the more established, longer-studied option Cost is a tighter constraint and the $50 per injection pricing is important Your weight loss goal is moderate (10-15% of body weight) and semaglutides proven efficacy range is sufficient Your insurance covers Wegovy or Ozempic, making brand-name semaglutide accessible through a separate pharmacy benefit Choose Tirzepatide If: Maximum weight loss is the priority and you want the most clinically effective option currently available You have tried semaglutide and found the results plateaued before reaching your goal You have Type 2 diabetes, as tirzepatides dual mechanism produces stronger glycemic control alongside weight loss The cost difference between semaglutide and tirzepatide is manageable within your budget You are comfortable using HSA funds to offset the cost of the higher dose tiers What About Compounded Semaglutide and Tirzepatide
Effects of Semaglutide on Stroke subtypes in type 2 diabetes: Post Hoc Analysis of the Randomized SUSTAIN 6 and PIONEER 6
Prices as reported in 2026
Key differences between Zepbound and Wegovy While these two weight-loss medications both fall under the class of GLP-1 drugs, they differ in key ways and it may impact which is right for you
Some people use GLP-1 medication for several months, while others may need longer-term care
Subcutaneous bioavailability is high, meaning most of the medication reaches your bloodstream and produces its intended effects
